Literature DB >> 16403122

Doxycycline for the treatment of paronychia induced by the epidermal growth factor receptor inhibitor cetuximab.

K-Y Shu, H L Kindler, M Medenica, M Lacouture.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16403122     DOI: 10.1111/j.1365-2133.2005.07010.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  5 in total

Review 1.  Infectious complications associated with monoclonal antibodies and related small molecules.

Authors:  Edsel Maurice T Salvana; Robert A Salata
Journal:  Clin Microbiol Rev       Date:  2009-04       Impact factor: 26.132

2.  A randomized phase 2 trial of the efficacy and safety of a novel topical povidone-iodine formulation for Cancer therapy-associated Paronychia.

Authors:  Kara D Capriotti; Milan Anadkat; Jennifer Choi; Benjamin Kaffenberger; Beth McLellan; Samuel Barone; Oluwaseun Kukoyi; Shari Goldfarb; Mario Lacouture
Journal:  Invest New Drugs       Date:  2019-06-26       Impact factor: 3.850

3.  1064 Nd:YAG laser for the treatment of chronic paronychia: a pilot study.

Authors:  M H M El-Komy; N Samir
Journal:  Lasers Med Sci       Date:  2013-12-11       Impact factor: 3.161

Review 4.  Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities.

Authors:  Mario E Lacouture; Milan J Anadkat; René-Jean Bensadoun; Jane Bryce; Alexandre Chan; Joel B Epstein; Beth Eaby-Sandy; Barbara A Murphy
Journal:  Support Care Cancer       Date:  2011-06-01       Impact factor: 3.603

Review 5.  Nail Changes With Chemotherapeutic Agents and Targeted Therapies.

Authors:  Shankila Mittal; Niti Khunger; Satya Pal Kataria
Journal:  Indian Dermatol Online J       Date:  2022-01-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.